EGE GÜBRE SANAYII |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.4 TRY | +0.34% |
|
+3.95% | +5.52% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 217 | 498 | 1,452 | 2,250 | 4,212 | 4,492 |
| Enterprise Value (EV) 1 | 250.4 | 610.4 | 1,561 | 2,278 | 4,168 | 4,017 |
| P/E ratio | 7.63 x | 11 x | 14.2 x | 19.1 x | 6.78 x | 12.4 x |
| Yield | - | - | 1.72% | 1.33% | 1.42% | - |
| Capitalization / Revenue | 0.55 x | 0.87 x | 1.97 x | 2.71 x | 3.41 x | 1.98 x |
| EV / Revenue | 0.64 x | 1.07 x | 2.12 x | 2.75 x | 3.37 x | 1.77 x |
| EV / EBITDA | 2.61 x | 6.47 x | 9.53 x | 8.79 x | 8.8 x | 6.81 x |
| EV / FCF | 5.1 x | 23.5 x | 41.5 x | 30.2 x | 78.3 x | 9.38 x |
| FCF Yield | 19.6% | 4.25% | 2.41% | 3.31% | 1.28% | 10.7% |
| Price to Book | 1.15 x | 2.25 x | 4.76 x | 5.66 x | 4.3 x | 1.08 x |
| Nbr of stocks (in thousands) | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| Reference price 2 | 2.170 | 4.980 | 14.52 | 22.50 | 42.12 | 44.92 |
| Announcement Date | 2/21/19 | 2/20/20 | 2/25/21 | 2/24/22 | 2/22/23 | 3/20/24 |
1TRY in Million2TRY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 391.7 | 570.2 | 735.3 | 829.5 | 1,237 | 2,266 |
| EBITDA 1 | 95.79 | 94.4 | 163.8 | 259.1 | 473.8 | 589.5 |
| EBIT 1 | 88.01 | 83.43 | 144.9 | 234.4 | 439.2 | 388.6 |
| Operating Margin | 22.47% | 14.63% | 19.71% | 28.26% | 35.51% | 17.15% |
| Earnings before Tax (EBT) 1 | 36.84 | 51.25 | 112.1 | 160.6 | 351.5 | 360.4 |
| Net income 1 | 28.43 | 45.31 | 102.2 | 118 | 621.2 | 370.2 |
| Net margin | 7.26% | 7.95% | 13.9% | 14.22% | 50.22% | 16.33% |
| EPS 2 | 0.2843 | 0.4531 | 1.022 | 1.180 | 6.212 | 3.627 |
| Free Cash Flow 1 | 49.08 | 25.95 | 37.62 | 75.47 | 53.24 | 428.3 |
| FCF margin | 12.53% | 4.55% | 5.12% | 9.1% | 4.3% | 18.9% |
| FCF Conversion (EBITDA) | 51.24% | 27.49% | 22.97% | 29.13% | 11.24% | 72.66% |
| FCF Conversion (Net income) | 172.67% | 57.26% | 36.81% | 63.97% | 8.57% | 115.71% |
| Dividend per Share | - | - | 0.2500 | 0.3000 | 0.6000 | - |
| Announcement Date | 2/21/19 | 2/20/20 | 2/25/21 | 2/24/22 | 2/22/23 | 3/20/24 |
1TRY in Million2TRY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 33.4 | 112 | 109 | 28.1 | - | - |
| Net Cash position 1 | - | - | - | - | 44.2 | 475 |
| Leverage (Debt/EBITDA) | 0.3487 x | 1.191 x | 0.6633 x | 0.1084 x | - | - |
| Free Cash Flow 1 | 49.1 | 25.9 | 37.6 | 75.5 | 53.2 | 428 |
| ROE (net income / shareholders' equity) | 15.8% | 22.1% | 38.8% | 33.6% | 90.2% | 9.19% |
| ROA (Net income/ Total Assets) | 17.4% | 11.3% | 14.9% | 17.7% | 23.9% | 5.37% |
| Assets 1 | 163.4 | 400.6 | 686.4 | 665.9 | 2,600 | 6,897 |
| Book Value Per Share 2 | 1.890 | 2.220 | 3.050 | 3.980 | 9.800 | 41.70 |
| Cash Flow per Share 2 | 0.0400 | 0.3300 | 1.080 | 1.400 | 2.220 | 4.070 |
| Capex 1 | 9.07 | 9.68 | 77.9 | 126 | 85 | 199 |
| Capex / Sales | 2.32% | 1.7% | 10.6% | 15.23% | 6.87% | 8.77% |
| Announcement Date | 2/21/19 | 2/20/20 | 2/25/21 | 2/24/22 | 2/22/23 | 3/20/24 |
1TRY in Million2TRY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +5.52% | 146M | |
| -18.23% | 14.29B | |
| -5.67% | 13.62B | |
| +14.17% | 13.1B | |
| -16.37% | 9.33B | |
| -11.18% | 7.5B | |
| -.--% | 7.38B | |
| -3.70% | 6.4B | |
| -4.05% | 4.31B | |
| -27.44% | 2.38B |
- Stock Market
- Equities
- EGGUB Stock
- Financials Ege Gübre Sanayii